346 related articles for article (PubMed ID: 16374212)
1. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
Bower M; Palmieri C; Dhillon T
Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
5. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
6. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
7. The changing role of radiotherapy in AIDS-related malignancies.
Lukawska J; Cottrill C; Bower M
Clin Oncol (R Coll Radiol); 2003 Feb; 15(1):2-6. PubMed ID: 12602546
[TBL] [Abstract][Full Text] [Related]
8. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
Clayton G; Omasta-Martin A; Bower M
J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498
[No Abstract] [Full Text] [Related]
9. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
10. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
11. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Rabkin CS; Testa MA; Huang J; Von Roenn JH
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216
[TBL] [Abstract][Full Text] [Related]
13. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
14. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
15. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
[No Abstract] [Full Text] [Related]
16. AIDS-related cancers in the era of highly active antiretroviral therapy.
Biggar RJ
Oncology (Williston Park); 2001 Apr; 15(4):439-48; discussion 448-9. PubMed ID: 11346932
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of AIDS-related tumours in developed and developing countries.
Dal Maso L; Serraino D; Franceschi S
Eur J Cancer; 2001 Jul; 37(10):1188-201. PubMed ID: 11423251
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
20. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]